Document is current

Article History

Received: 16 September 2024

Accepted: 11 October 2024

First Online: 28 October 2024

Declarations

:

: Joshua Coulter, Louis Baig, Amy Antipas, Sally-Anne Dewes, Colm Doody, and Brett Hauber are employees of Pfizer and hold stock or stock options in Pfizer Inc. Michaela Ogden-Barker was an employee of Pfizer when this study was conducted. Debra Montague and Angela Terry have no conflicts to declare and were paid consultants of Pfizer in connection with the development of this manuscript.

: The study was conducted in accordance with the Declaration of Helsinki. In the advisory board, the participants were advisors rather than research subjects. Each patient advisor was contracted individually, consistent with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice (). Participation in the advisory board was voluntary. Each contract outlined the objective and procedures of the advisory board, and specified remuneration, privacy, handling of personal data (consistent with EU and UK data protection regulations), and confidentiality. The extrapolation survey was determined not to require review by an NHS Research Ethics Committee (REC) using the NHS REC Decision Tool (). Participants who completed the extrapolation survey provided informed consent. With regard to publication, all participants and advisors were informed “Your answers will be analysed together with information from other respondents. We may share or publish the results from this survey as overall summary data that includes information from all respondents combined. Your identity will remain confidential”.